Mannkind Corp (MNKD): Insider Trading, Congress Trades & Research | Tormere

MNKD

$3.80-3.80%website ↗⬇ financials (.py)

MANNKIND CORP

Market Cap

$1.2B

Live price × shares (2026-09-17)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.08

60mo monthly vs SPY

P/E (TTM)

N/M

Price / TTM net income

P/S (TTM)

3.1

Price / TTM revenue

P/B

N/M

Price / stockholders equity

EV/EBITDA

49.2

TTM

Price Chart

Loading…

Signals

Insider Velocity

Market & Alt Data

News

15

recent articles

Analyst Consensus

Strong Buy

14 analysts

Velocity Score

7.59x

Sell Rate (90d)

2091.71/mo

Sell Baseline

684.71/mo

Unique Sellers (90d)

2

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-09-25	2026-09-28	Binder Steven B.	Director	Sale	39.1K	$3.29	$128K	713.3K	View
2026-09-10	2026-09-14	Binder Steven B.	Director	Sale	33.6K	$3.81	$128K	752.3K	View
2026-08-07	2026-08-10	Binder Steven B.	Director	Sale	39.1K	$4.06	$159K	785.9K	View
2026-07-17	2026-07-17	Binder Steven B.	Director	Sale	52.5K	$4.06	$213K	824.9K	View
2026-07-17	2026-07-17	Thomson David	EVP Genl Counsel & Secretary	Sale	24.1K	$4.05	$98K	797.6K	View

1–5 of 12

1 / 3

Reporting Insiders

Steven B. Binder
Director
4 transactions · last 2026-09-25
David Thomson
EVP Genl Counsel & Secretary
1 transaction · last 2026-07-17
Steven B. Binder
Director
1 transaction · last 2026-05-12
David Thomson
EVP Genl Counsel & Secretary
5 transactions · last 2026-05-12
Michael Castagna
Director & Chief Executive Officer
1 transaction · last 2026-03-10

Recent News

United Therapeutics: The Market Sees The Erosion, Not The Refill - Buy

SeekingAlpha · 2026-09-27

MannKind Sees Early ReadyFlow Demand as Pediatric Afrezza Launch Gains Momentum

Yahoo · 2026-09-17

MannKind (MNKD) Bets On Inhaled Weight Loss Amid Widening Losses

Yahoo · 2026-09-16

Cantor Fitzgerald Reiterates Overweight on MannKind, Maintains $8 Price Target

Benzinga · 2026-09-11

MannKind Expands Into Weight Loss With Rose Pharma Deal – Here’s What Investors Are Watching

Yahoo · 2026-09-09

Breathing In GLP-1: MannKind Partners With Rose Pharma for Inhaled Weight Management Molecule

Benzinga · 2026-09-09

MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management

Yahoo · 2026-09-09

MannKind And Rose Pharma Enter Into Worldwide Licensing And Collaboration Agreement To Develop ROSE-010 Technosphere For Weight Management

Benzinga · 2026-09-09

FDA Approves Mannkind's At-Home Treatment Option for Heart Failure or Kidney Disease

Yahoo Finance · 2026-07-27

What This MannKind Filing Reveals About Three Years of Underperformance

Yahoo Finance · 2026-07-20

What This MannKind Director Sale Signals With $32.7 Million in Quarterly Royalties Revenue Potentially at Risk

Yahoo Finance · 2026-07-20

What This MannKind Sale Signals With Tyvaso Royalties at $32.7 Million

Yahoo Finance · 2026-07-20

Why This MannKind Insider Stock Sale Matters Less Than a 9% Royalty at Risk

Yahoo Finance · 2026-07-20

Is MannKind Corporation (MNKD) A Good Stock To Buy Now?

Yahoo Finance · 2026-06-29

Wells Fargo Calls MannKind Corporation (MNKD)’s Commercial Potential a “Show-Me Story”

Yahoo Finance · 2026-06-13

Informational purposes only, not investment advice.

Recent Insider Activity (Form 4) — Last 5

Date	Insider	Type	Shares	Value
2026-09-25	Binder Steven B.	S	39,051	$128,477.79
2026-09-10	Binder Steven B.	S	33,558	$127,855.98
2026-08-07	Binder Steven B.	S	39,051	$158,547.06
2026-07-17	Binder Steven B.	S	52,485	$213,089.1
2026-07-17	Thomson David	S	24,109	$97,641.45